Sunwin Stevia International, Inc. produces and sells stevioside, a natural sweetener; and other pharmaceutical products primarily in the People's Republic of China. It operates through two segments, Natural Sweetener (Stevioside); and Corporate and Other Pharmaceutical. The company produces and sells various steviol glycosides with rebaudioside A and stevioside as the principal components. It provides Steviosin, a low calorie stevia extract for medicinal use; and OnlySweet, a zero calorie, dietary supplement to food and drug manufacturers, and ingredient distributor foreign trade companies. The company also produces and sells Metformin, a medication for the treatment of type 2 diabetes. Sunwin Stevia International, Inc. is based in Qufu, China.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [01/16/2020 07:42 PST] SUWN Expected to Trade Up After Bullish Patterns Develop
• [01/15/2020 07:47 PST] SUWN Expected to Trade Up After Bullish Patterns Develop
• [01/13/2020 10:10 PST] Sunwin Stevia International, Inc. (OTC:SUWN), Down By 100.00% ($0.06) From $0.061 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
• [01/13/2020 07:53 PST] SUWN Expected to Trade Down After Bearish Patterns Develop